Evidence map›Paper›PMID 29170885›Full record

ReviewJournal of cell communication and signaling2018

The structure of the S-layer of Clostridium difficile.

William J Bradshaw, April K Roberts, Clifford C Shone, K Ravi Acharya

Abstract readReview
In one paragraph

Review in Journal of cell communication and signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Cytoplasmic membrane vesicles fromFrontiers in microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Microorganisms · 2023
    Article
  10. Article
  11. Microbiology (Reading, England) · 2023
    Review
  12. Design of 8-mer Peptides that BlockbioRxiv : the preprint server for biology · 2023
    Article
  13. Review
  14. Improvement of the Lyophilization Survival Rate ofFoods (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

William J BradshawDepartment of Biology and Biochemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK.
April K RobertsPublic Health England, Porton Down, Salisbury, SP4 0JG, UK.
Clifford C ShonePublic Health England, Porton Down, Salisbury, SP4 0JG, UK.
K Ravi AcharyaDepartment of Biology and Biochemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK. bsskra@bath.ac.uk.ORCID http://orcid.org/0000-0002-3009-4058

Funding

Medical Research Council MR/K027123/1
6 · The paper itself

Abstract

The nosocomially acquired pathogen Clostridium difficile is the primary causative agent of antibiotic associated diarrhoea and causes tens of thousands of deaths globally each year. C. difficile presents a paracrystalline protein array on the surface of the cell known as an S-layer. S-layers have been demonstrated to possess a wide range of important functions, which, combined with their inherent accessibility, makes them a promising drug target. The unusually complex S-layer of C. difficile is primarily comprised of the high- and low- molecular weight S-layer proteins, HMW SLP and LMW SLP, formed from the cleavage of the S-layer precursor protein, SlpA, but may also contain up to 28 SlpA paralogues. A model of how the S-layer functions as a whole is required if it is to be exploited in fighting the bacterium. Here, we provide a summary of what is known about the S-layer of C. difficile and each of the paralogues and, considering some of the domains present, suggest potential roles for them.

Indexed as

Bacterial adhesionC. difficile InfectionCell wall proteinClostridium DifficileColitisS-layer

Identifiers

PMID29170885
PMCPMC5842191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.